Rockwell Competitors

Stocks . USA . 
Stock . Rockwell Medical
RMTI Stock  USD 1.07  0.02  1.83%   
Rockwell Medical competes with Cumberland Pharmaceuticals, Quantum BioPharma, Apimeds Pharmaceuticals, Liminatus Pharma, and Alterity Therapeutics; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Rockwell Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Rockwell Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Rockwell Medical Correlation with its peers.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Rockwell Medical vs Mural Oncology Correlation

Moving against Rockwell Stock

  0.42CSCO Cisco SystemsPairCorr
  0.37JPM JPMorgan ChasePairCorr
  0.33TLKMF Telkom Indonesia TbkPairCorr
  0.33AXP American ExpressPairCorr
  0.32PPERY Bank Mandiri Persero Earnings Call This WeekPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rockwell Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.051.076.98
Details
Intrinsic
Valuation
LowRealHigh
0.040.886.79
Details
Naive
Forecast
LowNextHigh
0.020.986.89
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.771.011.26
Details

Rockwell Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Rockwell Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Rockwell and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Rockwell Medical does not affect the price movement of the other competitor.

High positive correlations

NMTC
+ 0.79
CPIX
LIMN
+ 0.76
APUS
ATHE
+ 0.73
LIMN
ATHE
+ 0.7
APUS
TLPH
+ 0.67
LIMN
STRR
+ 0.65
CPIX
  

High negative correlations

APUS
- 0.76
CPIX
TLPH
- 0.74
CPIX
NMTC
- 0.7
TLPH
LIMN
- 0.67
CPIX
ATHE
- 0.57
CPIX
EVAX
- 0.55
NMTC

Risk-Adjusted Indicators

There is a big difference between Rockwell Stock performing well and Rockwell Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rockwell Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CPIX  4.45  0.64  0.13  0.69  4.55 
(5.42)
 12.60 
(7.76)
 27.96 
QNTM  6.27 (1.04) 0.00 (0.27) 0.00 
 0.00 
 13.19 
(12.78)
 59.29 
APUS  7.04 (0.04) 0.00  0.02  8.92 
(9.14)
 15.05 
(20.79)
 59.03 
LIMN  5.44 (1.18) 0.00 (0.30) 0.00 
 0.00 
 7.69 
(10.98)
 53.06 
ATHE  3.01 (0.34) 0.00 (0.70) 0.00 
 0.00 
 5.71 
(7.44)
 17.55 
STRR  1.85 (0.09) 0.00 (1.16) 0.00 
 0.00 
 3.21 
(4.79)
 12.75 
TLPH  3.51 (0.44) 0.00  0.42  0.00 
 0.00 
 6.03 
(9.22)
 32.54 
NMTC  3.70  0.34  0.07  0.65  3.88 
(4.79)
 9.59 
(6.85)
 23.46 
EVAX  4.43 (0.80) 0.00  1.22  0.00 
 0.00 
 9.15 
(10.68)
 37.88 
MURA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 

Rockwell Medical Competitive Analysis

The better you understand Rockwell Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Rockwell Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Rockwell Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
RMTI CPIX QNTM APUS LIMN ATHE STRR TLPH NMTC EVAX
 1.83 
 1.07 
Rockwell
 1.35 
 3.75 
Cumberland
 5.95 
 4.58 
Quantum
 4.15 
 1.85 
Apimeds
 6.78 
 0.55 
Liminatus
 2.76 
 3.17 
Alterity
 0.77 
 10.27 
Star
 1.03 
 0.96 
Talphera
 2.30 
 0.89 
Neuroone
 6.47 
 3.18 
Evaxion
Market Volatility
(90 Days Market Risk)
Abnormally volatile
Very risky
Very risky
Abnormally volatile
Out of control
Risky
Somewhat reliable
Abnormally volatile
Abnormally volatile
Very risky
Market Performance
(90 Days Performance)
Weak
Fair
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Mild
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Risky
Small
Risky
High
Risky
Fair
Low
Risky
Low
Risky
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Sell
Strong Sell
Current Ratio
2.19
1.8
N/A
N/A
N/A
7.07
1.36
0.64
13.42
6.47
Net Asset
59.21 M
75.58 M
17.12 M
13.06 K
2.83 M
46.03 M
52.58 M
18.24 M
10.79 M
12.48 M
Profit Margin
-0.073
-0.0806
N/A
N/A
N/A
-2.23
-0.0322
N/A
-0.8
-0.71
EBITDA
2.95 M
182.42 K
(14.38 M)
(1.27 M)
(2.75 M)
(14.63 M)
(4.81 M)
(15.16 M)
(3.01 M)
(9.79 M)
Operating Margin
-0.0995
-0.24
N/A
N/A
N/A
-1.86
-0.0676
N/A
-1.11
0.4
Current Valuation
32.37 M
50.38 M
19.95 M
21.11 M
160.23 M
32.73 M
40.84 M
24.11 M
37.57 M
24.89 M
Price To Book
1.16
2.15
2.0
N/A
N/A
1.93
0.53
2.33
6.2
4.81
Retained Earnings
(397.68 M)
(23.97 M)
(172.11 M)
(4.39 M)
(17.52 M)
(225.89 M)
(430.02 M)
(457.23 M)
(78.61 M)
(118.54 M)
Current Asset
84.63 M
66.96 M
N/A
N/A
N/A
14.26 M
N/A
9.04 M
94.49 M
N/A
Beta
1.65
-0.53
0.72
N/A
0.17
0.02
0.47
0.3
0.68
0.3
Number Of Employees
244
91
12
2
5
9
980
13
18
46
Shares Outstanding
39.41 M
14.96 M
3.84 M
11.58 M
26.01 M
18.13 M
3.47 M
46.61 M
50 M
8.34 M
Cash Flow From Operations
4.2 M
(612.19 K)
(6.88 M)
(733.53 K)
(3.11 M)
(11.45 M)
(5.18 M)
(12.68 M)
(2.84 M)
(12.94 M)
Total Debt
13.54 M
20.57 M
824.92 K
596.84 K
5.12 M
155.46 K
1.06 M
6.53 M
266.81 K
10.1 M
Return On Equity
-0.17
-0.13
-2.51
N/A
N/A
-0.43
-0.0866
-0.86
-0.95
-0.65
Return On Asset
-0.0525
-0.0286
-0.72
-4.09
N/A
-0.28
-0.038
-0.31
-0.45
-0.26
Number Of Shares Shorted
580.56 K
100.83 K
46.99 K
3.22 K
68.1 K
335
4.94 K
1.22 M
49.41 K
105.48 K
Book Value Per Share
0.94
1.75
2.27
-0.22
N/A
0.0035
19.72
0.42
0.16
2.61
Current Liabilities
8.09 M
11.69 M
N/A
N/A
N/A
1.73 M
N/A
14.14 M
18.26 M
N/A
Total Asset
59.21 M
75.58 M
17.12 M
13.06 K
2.83 M
46.03 M
52.58 M
18.24 M
10.79 M
12.48 M
Debt To Equity
1.38
0.5
N/A
N/A
N/A
0.003
0.42
0.17
0.021
0.48
Short Ratio
2.39
0.35
0.58
0.01
0.11
0.02
0.97
2.58
0.11
1.31
Target Price
3.75
8.5
44.92
N/A
N/A
12.0
17.0
3.25
2.23
14.19
Shares Owned By Institutions
9.02
23.02
28.86
N/A
N/A
1.85
32.22
38.8
34.73
5.88
Market Capitalization
42.16 M
56.1 M
17.6 M
24.31 M
145.16 M
57.46 M
35.67 M
44.56 M
33.89 M
26.52 M
Price To Earning
-14.72
-16.05
N/A
N/A
N/A
-4.84
N/A
N/A
-23.53
N/A
Price To Earnings To Growth
-0.79
N/A
N/A
N/A
N/A
N/A
2.03
N/A
N/A
N/A
Price To Sales
0.56
1.36
91.86
N/A
N/A
10.56
0.24
1591.39
3.7
3.47
Net Income
(480 K)
(6.48 M)
(14.92 M)
(1.39 M)
(2.9 M)
(12.15 M)
(10.44 M)
(13 M)
(3.61 M)
(10.57 M)
Earnings Per Share
-0.18
-0.24
-9.55
-0.13
-0.16
-0.58
-1.58
-0.38
-0.16
-4.0
Shares Owned By Insiders
12.39
41.63
8.64
81.96
82.68
N/A
35.19
28.41
11.7
18.38
Revenue
101.49 M
37.87 M
N/A
N/A
N/A
5.44 M
53.36 M
N/A
12.1 M
3.34 M
Working Capital
22.94 M
4.83 M
5.37 M
(1.01 M)
(15.79 M)
42.34 M
11.94 M
6.77 M
7.92 M
4.4 M
Cash And Equivalents
27.56 M
18.22 M
N/A
N/A
N/A
34.81 M
16.21 M
90.29 K
10.18 M
25.25 M
Cash Per Share
2.37
1.24
N/A
N/A
N/A
0.87
1.08
0.01
0.63
1.06
Gross Profit
11.45 M
34.88 M
N/A
N/A
N/A
5.31 M
14.04 M
(5.77 M)
(1.23 M)
7.65 M
Day Typical Price
1.08
3.77
4.69
1.87
0.56
3.16
10.17
0.96
0.89
3.24
Accumulation Distribution
0.0541
0.0982
0.0964
0.0863
0.1
0.0554
0.0435
0.051
0.0543
0.068
Market Facilitation Index
0.06
0.39
0.48
0.17
0.06
0.18
0.45
0.05
0.05
0.23
Daily Balance Of Power
(0.33)
0.1282
(0.60)
(0.47)
(0.67)
(0.50)
(0.18)
(0.20)
0.4
(0.96)
Period Momentum Indicator
(0.02)
0.05
(0.29)
(0.08)
(0.04)
(0.09)
(0.08)
(0.01)
0.02
(0.22)
Rate Of Daily Change
0.98
1.01
0.94
0.96
0.93
0.97
0.99
0.99
1.02
0.94
Day Median Price
1.08
3.78
4.74
1.89
0.57
3.16
10.13
0.96
0.9
3.26
Price Action Indicator
(0.02)
N/A
(0.31)
(0.07)
(0.04)
(0.04)
0.1
N/A
0.005
(0.19)
Relative Strength Index
53.0
N/A
36.15
47.61
36.32
45.21
45.07
40.36
N/A
58.66
Coefficient Of Variation
4125.81
921.22
(1,050)
23606.06
(830.20)
(1,265)
(3,319)
(1,124)
1328.71
(723.38)
Mean Deviation
3.83
4.45
6.27
7.04
5.44
3.01
1.85
3.51
3.7
4.43
Jensen Alpha
0.142
0.6383
(1.04)
(0.04)
(1.18)
(0.34)
(0.09)
(0.44)
0.3442
(0.80)
Total Risk Alpha
(0.15)
0.3687
(1.39)
(0.46)
(1.47)
(0.51)
(0.21)
(0.74)
0.1238
(1.11)
Sortino Ratio
0.0214
0.1273
N/A
(0.0002)
N/A
N/A
N/A
N/A
0.0721
N/A
Downside Variance
21.22
25.07
N/A
91.98
N/A
N/A
N/A
N/A
20.81
N/A
Standard Deviation
5.91
6.29
9.62
10.21
8.65
3.92
2.61
5.34
4.97
5.91
Kurtosis
11.99
1.84
6.89
1.65
9.73
0.3619
1.09
4.06
0.813
1.94
Potential Upside
6.38
12.6
13.19
15.05
7.69
5.71
3.21
6.03
9.59
9.15
Treynor Ratio
(0.54)
0.6875
(0.27)
0.017
(0.30)
(0.70)
(1.16)
0.4177
0.648
1.22
Maximum Drawdown
40.19
27.96
59.29
59.03
53.06
17.55
12.75
32.54
23.46
37.88
Variance
34.98
39.53
92.54
104.17
74.75
15.39
6.8
28.52
24.67
34.91
Market Risk Adjusted Performance
(0.53)
0.6975
(0.26)
0.027
(0.29)
(0.69)
(1.15)
0.4277
0.658
1.23
Risk Adjusted Performance
0.0263
0.0874
(0.06)
0.0124
(0.08)
(0.05)
(0.01)
(0.06)
0.063
(0.09)
Skewness
2.55
0.9838
2.02
0.2235
1.19
(0.14)
(0.21)
(0.12)
0.6539
0.2671
Semi Deviation
4.1
4.55
N/A
8.92
N/A
N/A
N/A
N/A
3.88
N/A
Information Ratio
0.0166
0.1014
(0.1)
(0.0002)
(0.13)
(0.09)
(0.05)
(0.1)
0.0662
(0.15)
Value At Risk
(6.52)
(7.76)
(12.78)
(20.79)
(10.98)
(7.44)
(4.79)
(9.22)
(6.85)
(10.68)
Expected Short fall
(4.71)
(5.42)
N/A
(9.14)
N/A
N/A
N/A
N/A
(4.79)
N/A
Downside Deviation
4.61
5.01
N/A
9.59
N/A
N/A
N/A
N/A
4.56
N/A
Semi Variance
16.83
20.69
N/A
79.51
N/A
N/A
N/A
N/A
15.08
N/A

Rockwell Medical Competition Performance Charts

Five steps to successful analysis of Rockwell Medical Competition

Rockwell Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Rockwell Medical in relation to its competition. Rockwell Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Rockwell Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Rockwell Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Rockwell Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Rockwell Medical position

In addition to having Rockwell Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recreation Thematic Idea Now

Recreation
Recreation Theme
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
How To Invest In Rockwell
Details
Is Rockwell Stock a good investment?
Details
What is Rockwell Medical's Net Worth?
Details
Top Sectors
View
Check out Rockwell Medical Correlation with its peers.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is there potential for Stock market expansion? Will Rockwell introduce new products? Factors like these will boost the valuation of Rockwell Medical. Anticipated expansion of Rockwell directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
It's important to distinguish between Rockwell Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rockwell Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Rockwell Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY